Bulletin

Press Information Bureau

India achieves the major milestone of ‘one billion’ vaccinations

October 21, 2021

Press Information Bureau

Dr. Bharati Pravin Pawar, Union Minister of State for Health and Family Welfare virtually addressestheAnnual FICCI Healthcare Excellence Awards Ceremony

October 20, 2021

Press Information Bureau

“Pradhan Mantri Garib Kalyan Package: Insurance Scheme for Health Workers fighting COVID-19”, extended for a further period of 180 days

October 20, 2021

WHO

House-to-house polio vaccination set to recommence across Afghanistan in November

October 18, 2021

Press Information Bureau

Dr. Mansukh Mandaviya, Union Minister of Health and Family Welfare, virtually lay the foundation for the new building of ICMR School of Public Health at ICMR- NIE, Chennai

October 16, 2021

LSW

US FDA approves Roche’s Tecentriq as adjuvant treatment for certain people with early non-small cell lung cancer

October 16, 2021

WHO

Tuberculosis deaths rise for the first time in more than a decade due to the COVID-19 pandemic

October 14, 2021

WHO

Democratic Republic of the Congo starts Ebola vaccination

October 14, 2021

WHO

WHO calls for better and fairer opportunities for physical activity to improve health

October 14, 2021

WHO

WHO Announces Proposed Members of its Scientific Advisory Group for the Origins of Novel Pathogens (SAGO)

October 14, 2021

WHO

Disease Outbreak News (DON) - Zika Virus Disease - India

October 14, 2021

WHO

VPC on the launch of the 2021 Global Tuberculosis Report, 14 October

October 14, 2021

Press Information Bureau

Deparment of Pharmaceuticals to organize a Felicitation Ceremony for winners of ‘Pharma & Medical Devices Startup Grand Challenge’ on 18th October 2021

October 14, 2021

Roche

Data up to 8-years for Roche’s OCREVUS (ocrelizumab) show early and ongoing treatment significantly reduced risk of requiring a walking aid in relapsing multiple sclerosis and disability progression in primary progressive multiple sclerosis

October 13, 2021

Press Information Bureau

Dr Bharati Pravin Pawar launches Phase II of Awareness Campaigns on HIV/AIDS & TB under ‘Azadi ka Amrit Mahotsav’

October 12, 2021

Roche

Roche’s anti-amyloid beta antibody gantenerumab granted FDA Breakthrough Therapy Designation in Alzheimer’s disease

October 11, 2021

< 1 … 75 76 77 78 79 80 81 82 83 … 94 >

Bulletin

India achieves the major milestone of ‘one billion’ vaccinations

Dr. Bharati Pravin Pawar, Union Minister of State for Health and Family Welfare virtually addressestheAnnual FICCI Healthcare Excellence Awards Ceremony

“Pradhan Mantri Garib Kalyan Package: Insurance Scheme for Health Workers fighting COVID-19”, extended for a further period of 180 days

House-to-house polio vaccination set to recommence across Afghanistan in November

Dr. Mansukh Mandaviya, Union Minister of Health and Family Welfare, virtually lay the foundation for the new building of ICMR School of Public Health at ICMR- NIE, Chennai

US FDA approves Roche’s Tecentriq as adjuvant treatment for certain people with early non-small cell lung cancer

Tuberculosis deaths rise for the first time in more than a decade due to the COVID-19 pandemic

Democratic Republic of the Congo starts Ebola vaccination

WHO calls for better and fairer opportunities for physical activity to improve health

WHO Announces Proposed Members of its Scientific Advisory Group for the Origins of Novel Pathogens (SAGO)

Disease Outbreak News (DON) - Zika Virus Disease - India

VPC on the launch of the 2021 Global Tuberculosis Report, 14 October

Deparment of Pharmaceuticals to organize a Felicitation Ceremony for winners of ‘Pharma & Medical Devices Startup Grand Challenge’ on 18th October 2021

Data up to 8-years for Roche’s OCREVUS (ocrelizumab) show early and ongoing treatment significantly reduced risk of requiring a walking aid in relapsing multiple sclerosis and disability progression in primary progressive multiple sclerosis

Dr Bharati Pravin Pawar launches Phase II of Awareness Campaigns on HIV/AIDS & TB under ‘Azadi ka Amrit Mahotsav’

Roche’s anti-amyloid beta antibody gantenerumab granted FDA Breakthrough Therapy Designation in Alzheimer’s disease

Company

Resources